Feng Y - Search Results

1

Age-specific effects of early MK-801 treatment on working memory in female rats.

Su YA, Wang XD, Li JT, Guo CM, Feng Y, Yang Y, Huang RH, Si TM. Su YA, et al. Among authors: feng y. Neuroreport. 2011 Jun 11;22(8):402-6. doi: 10.1097/WNR.0b013e328346e154. Neuroreport. 2011. PMID: 21532396

2

Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.

Feng Y, Wang XD, Guo CM, Yang Y, Li JT, Su YA, Si TM. Feng Y, et al. J Biomed Biotechnol. 2010;2010:859516. doi: 10.1155/2010/859516. Epub 2010 May 4. J Biomed Biotechnol. 2010. PMID: 20467458 Free PMC article.

3

Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats.

Li JT, Su YA, Guo CM, Feng Y, Yang Y, Huang RH, Si TM. Li JT, et al. Among authors: feng y. Eur J Pharmacol. 2011 Feb 10;652(1-3):65-72. doi: 10.1016/j.ejphar.2010.10.074. Epub 2010 Nov 27. Eur J Pharmacol. 2011. PMID: 21114996

4

Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.

Li JT, Feng Y, Su YA, Wang XD, Si TM. Li JT, et al. Among authors: feng y. Pharmacol Biochem Behav. 2013 Jul;108:44-53. doi: 10.1016/j.pbb.2013.04.008. Epub 2013 Apr 18. Pharmacol Biochem Behav. 2013. PMID: 23603030

5

Efficacy and safety of flexibly dosed paliperidone palmitate in Chinese patients with acute schizophrenia: an open-label, single-arm, prospective, interventional study.

Si T, Zhang K, Tang J, Fang M, Li K, Zhuo J, Feng Y. Si T, et al. Among authors: feng y. Neuropsychiatr Dis Treat. 2015 Jun 22;11:1483-92. doi: 10.2147/NDT.S81760. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26150719 Free PMC article.

6

Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety.

Si T, Zhuo J, Turkoz I, Mathews M, Tan W, Feng Y. Si T, et al. Among authors: feng y. Expert Opin Pharmacother. 2017 Dec;18(17):1799-1809. doi: 10.1080/14656566.2017.1401608. Epub 2017 Nov 15. Expert Opin Pharmacother. 2017. PMID: 29141463 Clinical Trial.

7

Li N, Feng Y, Lu H, Cai SL, Zhuo J, Si T, Zhang L. Li N, et al. Among authors: feng y. Neuropsychiatr Dis Treat. 2018 Mar 22;14:825-837. doi: 10.2147/NDT.S158353. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29606876 Free PMC article.

8

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.

Si T, Li N, Lu H, Cai S, Zhuo J, Correll CU, Zhang L, Feng Y. Si T, et al. Among authors: feng y. J Psychopharmacol. 2018 Jun;32(6):691-701. doi: 10.1177/0269881118772449. Epub 2018 May 16. J Psychopharmacol. 2018. PMID: 29764266 Free PMC article. Clinical Trial.

9

Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia.

Si T, Zhuo J, Feng Y, Lu H, Hong D, Zhang L. Si T, et al. Among authors: feng y. Neuropsychiatr Dis Treat. 2019 Jun 27;15:1685-1694. doi: 10.2147/NDT.S191803. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31303756 Free PMC article.

10

Paliperidone Palmitate Improves and Maintains Functioning in Asia-Pacific Patients with Schizophrenia.

Zhang H, Turkoz I, Zhuo J, Mathews M, Tan W, Feng Y. Zhang H, et al. Among authors: feng y. Adv Ther. 2017 Nov;34(11):2503-2517. doi: 10.1007/s12325-017-0638-0. Epub 2017 Nov 3. Adv Ther. 2017. PMID: 29101715 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,652 results

Search Page

Filters